Keynote Speaker Bios

Serena Silver, Ph.D.

Serena Silver, Ph.D., is the Chief Scientific Officer at Accent Therapeutics (Lexington, MA, USA), a clinical-stage biotechnology company that aims to translate extraordinary science into life-changing therapeutics for patients living with cancer. Prior to joining Accent, Serena served as Vice President of Discovery Biology and Technologies at Fulcrum Therapeutics, where she led scientific teams to develop and deploy new assay modalities and complex cellular models of disease to identify targets and discover therapeutics for rare diseases. Previously, Serena led the Molecular Pharmacology group at Novartis Oncology, the Target ID & Validation team at Sanofi Oncology, and worked at the forefront of functional genomics screening technology at the Broad Institute. Dr. Silver earned a Ph.D. in Biology from the Massachusetts Institute of Technology and completed a postdoctoral fellowship at Harvard Medical School.